NCT04031950
Clinical Evaluation of a Paediatric Sleep Diagnosis Technology
At risk: Primary completion moved at least 1 year 11 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 10 versions: 10 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary and study completion dates pushed to Oct 14, 2027 Show 6 more changesShow less
- Enrollment increased: 200 → 345 participants
- Eligibility criteria expanded, about 52 words
- Trial arms changed: 2 → 5
- Study description expanded, about 188 words
- Site details revised at 1 of 2 sites
- Collaborators: details revised at 1 of 2 entries
- Notable Primary completion date: Dec 30, 2023 to Oct 30, 2025
- Study completion date: Dec 30, 2023 to Dec 30, 2025
- Notable Primary and study completion dates: Jun 30, 2023 to Dec 30, 2023
- Study sites: 1 to 2
- Notable Primary and study completion dates: Jun 30, 2022 to Jun 30, 2023
- Enrollment target: 150 to 200
- Collaborators: 1 to 2
- Notable Primary and study completion dates pushed to Jun 30, 2022v6
Show 4 earlier versionsHide 4 earlier versions
- Notable Primary completion date: Nov 30, 2020 to Nov 30, 2021
- Study completion date: Dec 30, 2020 to Dec 30, 2021
- Minor Site contact updatedv4
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Jan 25, 2020 to Feb 19, 2020
- Site details revised
- Notable Start date: Nov 1, 2019 to Jan 25, 2020
- Site contact updated
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Arms and interventions
Test group will wear PSG
THis group will wear the novel device
40 consecutive patients (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who will have been referred for at home diagnosis of sleep apnoea or overnight oximetry at home. Each site will recruit, in parallel, consecutive patients from the moment the first patient in this group is recruited at that site. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 8 years old and referral for overnight assessment for evaluation of possible sleep apnoea. Additionally, patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. This patient cohort will be used to assess the acceptance of the AcuPebble technology in the home environment.
30 patients will be recruited (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who are on mechanical ventilation and have been referred for diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 1 year old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study in hospital, or over 8 years old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study at home. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of diagnostic validity.
75 patients will be recruited (plus/minus 30% to account for potential dropouts, or invalid signals from the gold-standard), who have a BMI SDS score of 3 or more and have been referred for either at-home or in-hospital diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. If their study is to take place in the home, only children who are older than 8 will be included. If their study is to take place in hospital, children over the age of 1 will be included. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of sensitivity and specificity for this cohort.
Devices: Novel wearable paediatric device
Sites
2 sites in 1 country